SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-031977
Filing Date
2023-09-07
Accepted
2023-09-07 16:15:32
Documents
12
Period of Report
2023-09-07
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 34678
  Complete submission text file 0001493152-23-031977.txt   208872

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ards-20230907.xsd EX-101.SCH 3027
3 XBRL LABEL FILE ards-20230907_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE ards-20230907_pre.xml EX-101.PRE 22367
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3398
Mailing Address 983 UNIVERSITY AVENUE, BLDG. B LOS GATOS CA 95032
Business Address 983 UNIVERSITY AVENUE, BLDG. B LOS GATOS CA 95032 (408) 385-1742
Aridis Pharmaceuticals, Inc. (Filer) CIK: 0001614067 (see all company filings)

IRS No.: 320074500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38630 | Film No.: 231242428
SIC: 2834 Pharmaceutical Preparations